J. Gilabert

2.1k total citations
62 papers, 1.8k citations indexed

About

J. Gilabert is a scholar working on Hematology, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, J. Gilabert has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 15 papers in Obstetrics and Gynecology and 14 papers in Molecular Biology. Recurrent topics in J. Gilabert's work include Blood Coagulation and Thrombosis Mechanisms (29 papers), Pregnancy and preeclampsia studies (14 papers) and Protease and Inhibitor Mechanisms (11 papers). J. Gilabert is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (29 papers), Pregnancy and preeclampsia studies (14 papers) and Protease and Inhibitor Mechanisms (11 papers). J. Gilabert collaborates with scholars based in Spain, United States and United Kingdom. J. Gilabert's co-authors include Francisco España, A. Estellés, J Aznar, Amparo Estellés, Justo Aznar, Salvador Grancha, RR Schleef, Antonio R. Artalejo, John H. Griffin and A. Romeu and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

J. Gilabert

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Gilabert Spain 24 617 497 336 244 242 62 1.8k
Kayoko Maehara Japan 26 115 0.2× 468 0.9× 242 0.7× 142 0.6× 79 0.3× 57 1.5k
Brian Pedersen United States 17 800 1.3× 504 1.0× 46 0.1× 159 0.7× 73 0.3× 30 1.8k
M.H.F. Sullivan United Kingdom 28 119 0.2× 314 0.6× 602 1.8× 63 0.3× 111 0.5× 73 2.0k
James D. Moffatt United Kingdom 22 820 1.3× 669 1.3× 32 0.1× 253 1.0× 346 1.4× 41 2.2k
Christopher R. Burrow United States 26 288 0.5× 1.8k 3.5× 56 0.2× 59 0.2× 64 0.3× 47 2.7k
Kálmán Kovács Hungary 24 63 0.1× 344 0.7× 169 0.5× 92 0.4× 148 0.6× 107 1.5k
Tom E. Howard United States 18 475 0.8× 716 1.4× 50 0.1× 33 0.1× 75 0.3× 46 1.7k
Benjamin T. Jackson United States 25 94 0.2× 404 0.8× 192 0.6× 171 0.7× 26 0.1× 68 1.7k
R A Hutton United Kingdom 27 811 1.3× 290 0.6× 42 0.1× 44 0.2× 52 0.2× 66 2.4k
Magnus Gram Sweden 25 56 0.1× 378 0.8× 298 0.9× 85 0.3× 149 0.6× 75 1.4k

Countries citing papers authored by J. Gilabert

Since Specialization
Citations

This map shows the geographic impact of J. Gilabert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Gilabert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Gilabert more than expected).

Fields of papers citing papers by J. Gilabert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Gilabert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Gilabert. The network helps show where J. Gilabert may publish in the future.

Co-authorship network of co-authors of J. Gilabert

This figure shows the co-authorship network connecting the top 25 collaborators of J. Gilabert. A scholar is included among the top collaborators of J. Gilabert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Gilabert. J. Gilabert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilabert–Estellés, Juan, Luis Ramón, Aitana Braza‐Boïls, et al.. (2011). Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity. Thrombosis Research. 130(2). 242–247. 16 indexed citations
2.
Artalejo, Antonio R., et al.. (2006). ATP from Subplasmalemmal Mitochondria Controls Ca2+-dependent Inactivation of CRAC Channels. Journal of Biological Chemistry. 281(47). 35616–35623. 36 indexed citations
3.
4.
Gilabert, J.. (2000). Respiring mitochondria determine the pattern of activation and inactivation of the store-operated Ca2+ current ICRAC. The EMBO Journal. 19(23). 6401–6407. 194 indexed citations
5.
Albillos, Almudena, Luis Gandı́a, Pedro Michelena, et al.. (1996). The mechanism of calcium channel facilitation in bovine chromaffin cells.. The Journal of Physiology. 494(3). 687–695. 63 indexed citations
6.
Gilabert, J., Amparo Estellés, Antonio Rico Cano, et al.. (1995). The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status. American Journal of Obstetrics and Gynecology. 173(6). 1849–1854. 64 indexed citations
7.
8.
9.
Regañón, E., V. Vila, Begoña Laíz, J. Gilabert, & J Aznar. (1993). Decreased High-Molecular Weight Fibrinogen and Impaired Alpha-Chain Polymerization in Full-Term Newborns. Pathophysiology of Haemostasis and Thrombosis. 23(3). 149–158. 7 indexed citations
10.
España, Francisco, J. Gilabert, Vicente Vicente, et al.. (1992). Activated protein C:α1-antitrypsin (APC:α1AT) complex as a marker for diagnosis of prethrombotic states. Thrombosis Research. 66(5). 499–508. 11 indexed citations
11.
Pons, Ramón, et al.. (1991). [Malignant Mediterranean boutonneuse fever. Septic shock of unknown origin?].. PubMed. 188(4). 199–201. 1 indexed citations
12.
España, Francisco, et al.. (1991). Determination of total, free and complexed protein s in plasma by ELISA, and comparison with a standard electroimmunoassay. Thrombosis Research. 62(6). 615–624. 8 indexed citations
14.
Gilabert, J., et al.. (1990). Characteristics of arachidonic acid metabolism of human endothelial cells in culture. Cytotechnology. 3(1). 21–29. 4 indexed citations
15.
Estellés, Amparo, J. Gilabert, Cristina Andrés, Francisco España, & Justo Aznar. (1990). Plasminogen Activator Inhibitors Type 1 and Type 2 and Plasminogen Activators in Amniotic Fluid during Pregnancy. Thrombosis and Haemostasis. 64(2). 281–285. 34 indexed citations
16.
Fernández, José A., Amparo Estellés, J. Gilabert, Francisco España, & Justo Aznar. (1989). Functional and Immunologic Protein S in Normal Pregnant Women and in Full-Term Newborns. Thrombosis and Haemostasis. 61(3). 474–478. 47 indexed citations
17.
Gilabert, J., José A. Fernández, Francisco España, J Aznar, & A. Estellés. (1988). Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives. Thrombosis Research. 49(3). 319–329. 45 indexed citations
18.
Gilabert, J., et al.. (1987). Congenital Hypofibrinogenemia and Pregnancy, Obstetric and Hematological Management. Gynecologic and Obstetric Investigation. 24(4). 271–276. 9 indexed citations
19.
Gilabert, J., Francisco España, A. Estellés, & José A. Aznar. (1986). Functional and antigenic protein C and its inhibitor in normal pregnancy and preeclampsia. Thrombosis Research. 41. 162–162. 1 indexed citations
20.
Aznar, J, Alberto Hernández, Juan José Parrilla, A. Estellés, & J. Gilabert. (1976). Changes in Human Amniotic Fluid Fibrinolytic Inhibitor Levels during Pregnancy. Thrombosis and Haemostasis. 35(2). 382–385. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026